12
Figure 3. Adjuvant/Systemic Therapy Recommendations by
Resource Level
Basic
Limited
Enhanced
Should not
administer
adjuvant
chemotherapy
to patients
with early-
stage ovarian
borderline or
LMP tumors
or early-stage
micro-invasive
borderline
tumors
Basic and
Limited setting
recommendations
Surgically staged,
pathologic confirmed
epithelial, ovarian,
fallopian tube or
peritoneal cancer
If pathology
confirmation not
possible, cytologic
confirmation, CA-125
and imaging
Basic setting
recommendations
Adjuvant/Systemic Therapy for Stage I
Assess patient's
eligibility for
adjuvant
chemotherapy
OR
Treatment
